Navigation Links
Developing unique brain maps to assist surgery and research
Date:6/16/2008

Researchers from the Howard Florey Institute in Melbourne are developing new technology to create individualised brain maps that will revolutionise diagnosis of disease and enhance the accuracy of brain surgery.

Currently researchers and neurosurgeons rely on coarse maps of the brain's structure that are based on a small number of individuals' brains after death. These maps do not allow for differences that can occur between people's brains.

The new brain mapping technology will be created by developing acquisition and analysis processes and software that will provide microscopic level investigation of individual brains.

The Florey researchers are contributing neuroscience, engineering and mathematical expertise to this project, whilst collaborators from the Neuroscience Research Institute in South Korea are providing the equipment.

It is hoped this technology will become widely available in the next two to three years.

Leader of the Neuroimaging group at the Howard Florey Institute, A/Prof Gary Egan, said his group was using one of the most powerful Magnetic Resonance Imaging (MRI) scanners in the world an ultra-high field 7 Tesla to help develop the new brain mapping technology.

"Microscopic images inside the living brain will transform diagnosis and treatment of diseases such as multiple sclerosis, Parkinson's disease, Alzheimer's disease and Huntington's disease," A/Prof Egan said.

"This technology will allow us to look at cortical grey matter and underlying white matter at a level previously only seen before in post-mortem brains.

"Current MRI techniques cannot show specific organisation and functional patterns in the living brain.

"For example, developmental neuronal migration defects are known to cause epilepsy, but they cannot be seen with existing MRI technology.

"Ultra-high resolution imaging will allow scientists and doctors to clearly see defects in the brain and develop therapeutic strategies to address these problems," he said.

Unfortunately, Australia does not have a 7 Tesla scanner, which is why the Howard Florey Institute and University of Melbourne scientists are collaborating with the Neuroscience Research Institute in South Korea, who own the only high resolution 7 Tesla scanner in the Asia Pacific region.

The most powerful scanners in Australia are 3 Tesla, which are accessed by the Florey scientists for other research projects.

A/Prof Egan said he hoped a 7 Tesla scanner would very soon be located in Australia as neuroimaging can assist research into all brain and mind disorders.

"Having an ultra-high field 7 Tesla in Australia would allow us to accelerate our research, which would benefit the three million Australians who experience a major episode of brain disorder every year," he added.

This research will be presented at the 14th Annual Meeting of the Organisation for Human Brain Mapping, which opened yesterday in Melbourne. This conference, supported by the Howard Florey Institute, will see the world's neuroimaging experts share their latest research and develop new collaborations.


'/>"/>

Contact: Merrin Rafferty
merrin.rafferty@florey.edu.au
61-383-441-658
Research Australia
Source:Eurekalert

Related medicine news :

1. X-rays often repeated for patients in developing countries
2. Fortune 500s to Convene in Florida, Sharing Insights & Best Practices for Developing Tomorrows Leaders
3. Hypertension Takes Huge Toll in Developing Countries
4. Developing roadmaps for enhancing the professional culture of medical schools
5. Xceed Molecular Signs University of Florida to Strategic Collaborator Program; Focus on Developing New Molecular Test to Diagnose Early-Stage Bladder Cancer
6. Dubai Cares Announces 12 Country Plan to Educate and Empower Children in Developing Nations
7. Worldwide Pharmaceutical Industry Launches Global Health Progress Initiative to Expand Efforts to Improve Health in Developing Countries
8. Antipsychotic drugs increase risk of developing pneumonia in elderly
9. Developing cancer treatments directed at critical developmental pathway
10. Forgotten diseases key to lifting developing world from poverty, destitution and despair
11. Research Shows Patients With Psoriasis at Increased Risk for Developing Other Serious Medical Conditions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)... Washington, DC (PRWEB) , ... ... ... the Siemens Foundation today announced a new initiative—the Siemens Foundation-PATH Ingenuity Fellowships—to ... settings. The partnership will recruit top students from U.S. universities who will ...
(Date:2/12/2016)... Boca Raton, FL (PRWEB) , ... February 12, ... ... nation’s largest non-profit organization devoted exclusively to funding innovative lymphoma research and serving ... patient services – hosted over 250 members of South Florida’s philanthropic community at ...
(Date:2/12/2016)... ... February 12, 2016 , ... CDRH Enforcement Trends: , Back to the Future , ... , As Winston Churchill said, “Those who don’t learn from history are doomed to ... expect when they come knocking this year. But that takes time. , Take a ...
(Date:2/12/2016)... ... February 12, 2016 , ... Fixed Dose Combination ... 3:00 p.m. EST, http://www.fdanews.com/fixeddosecombination , Fixed dose combination ... garnering increased attention from all stakeholders in the development of new chemical entities. ...
(Date:2/12/2016)... (PRWEB) , ... February 12, 2016 , ... Each year, ... will be held in Anaheim, CA at the Anaheim Convention Center. Almost 10,000 physical ... see new therapy products in action, learn more about their chosen field and network ...
Breaking Medicine News(10 mins):
(Date:2/12/2016)... Va. , Feb. 12, 2016   National ... Hoey , RPh, MBA issued the following statement today ... released by the Centers for Medicare & ... raised by NCPA, beneficiary advocates and others: ... raised. We are still reviewing the full CMS analysis. ...
(Date:2/12/2016)...  This month,s issue of the Journal of ... in-depth look at various causes and consequences associated with rising health ... which has generated significant public outrage and calls for ... E. Happe , PharmD, MPH. --> JMCP ... --> In 2014 prescription drug spending in ...
(Date:2/12/2016)... PAULO , Feb. 12, 2016 ... commenced a cash tender offer (the "Tender Offer") ... million outstanding aggregate principal amount of its 6.500% ... and ISIN Nos. US44915JAA88/ USP5246AAF05) (the "Notes"). In ... soliciting (the "Consent Solicitation") consents (the "Consents") of ...
Breaking Medicine Technology: